Neoadjuvant Chemotherapy for Peripheral Blood Micrometastasis Factors in Patients of Breast Cancer 新辅助化疗对乳腺癌外周血微转移因子的影响
We compared neoadjuvant radiation, neoadjuvant chemoradiation with surgery alone and adjuvant therapy. 探讨了新辅助放疗、新辅助放化疗与单纯手术及辅助化放疗相比的优劣。
Neoadjuvant chemotherapy can reduce tumor loading, degrade the staging, afford operation possibility. 新辅助化疗能减少肿瘤负荷,降低原发肿瘤分期,增加手术切除的可能性。
The results also indicate that a complete response to neoadjuvant endocrine therapy is rare compared to neoadjuvant chemotherapy. 这项研究结果也显示,相比较新辅助化疗,罕见对新辅助内分泌治疗有完全的缓解。
Previous research suggests that neoadjuvant treatment with irinotecan-or oxaliplatin-based chemotherapy can make surgery more likely to succeed. 先前的研究显示以伊利替康或奥沙利铂为基础的化疗可以增加手术切除机会。
Neoadjuvant radiochemotherapy: A challenge for the treatment of rectal cancer? 新辅助治疗&对直肠癌现有治疗模式的挑战?
Clinical Research of Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer 新辅助化疗用于局部晚期宫颈癌临床研究
To investigate, the researchers studied stage II and II breast cancer patients who were receiving neoadjuvant chemotherapy. 研究人员对接受新辅助化疗的II期乳腺癌患者进行了研究。
Clinical observation of neoadjuvant chemotherapy in breast cancer with paclitaxel liposome and pirarubicin 紫杉醇脂质体联合吡柔比星在乳腺癌新辅助化疗中的临床观察
Recent findings The role of adjuvant or neoadjuvant therapy is being investigated, but there is no clear evidence supporting its routine use at this time. 最新的研究结果:人们正在对辅助疗法或新辅助疗法的作用进行研究,但是目前还没有明确的证据支持这些疗法可以常规使用。
Neoadjuvant chemotherapy followed by resection has become the mainstay in the treatment of hepatoblastoma ( HB). 肿瘤切除术前的新辅助化疗方案现已成为了肝母细胞瘤(HB)的一项主要治疗手段。
Glutathione Provides Protection for Patients with T3 Stage Rectal Cancer During Neoadjuvant Chemotherapy 谷胱甘肽对T3期直肠癌新辅助化疗患者的保护作用
This study assessed the outcome of LRRC patients treated with multimodality treatment, consisting of neoadjuvant radio ( chemo-) therapy, extended resection, and intraoperative radiotherapy. 该研究对接受综合模式治疗的LRRC患者进行了评估,该模式包括新辅助放化疗、扩大切除术和术中放疗。
Neoadjuvant Chemotherapy of Docetaxel Combined with Epirubicin for 30 Elderly Cases with Locally Advanced Breast Cancer 多西紫杉醇联合表柔比星新辅助化疗治疗老年局部晚期乳腺癌30例
Combination of docetaxel and capecitabine in the neoadjuvant chemotherapy of breast cancer 多西他赛联合卡培他滨在乳腺癌新辅助化疗中的应用
Applications of three neoadjuvant chemotherapy schemes in cervical cancer 三种新辅助化疗方案在宫颈癌治疗中的应用和比较
Therefore more high-level evidence-based medical researches are expected to evaluate the value of neoadjuvant therapy of pancreatic cancer. 因此需要进一步的高质量的循证医学证据来证实患者能否从新辅助治疗中获益,以期提高胰腺癌的治疗水平。
Objective to evaluate the efficacy of Paclitaxel in treatment of soft-tissue sarcoma receiving the neoadjuvant chemotherapy. 目的分析紫杉醇应用于软组织肉瘤的疗效。
Application of MRI in Breast-Conserving Surgery after Neoadjuvant Chemotherapy MRI在乳腺癌新辅助化疗后行保乳手术中的应用
Application of paclitaxel in neoadjuvant chemotherapy in patients with cervical cancer 紫杉醇在宫颈癌术前新辅助化疗中的应用
Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer 新辅助化疗FEC方案和TEC方案对乳腺癌患者的疗效
Clinical Observation of Neoadjuvant Intra-arterial Chemotherapy in Treatment of Cervical Cancer and the Effect on Cell Proliferation and Apoptosis 新辅助动脉化疗治疗宫颈癌的临床观察及对细胞增殖与凋亡的影响
Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease. 目前已证实,几种化疗药可作为某些转移性癌症患者的新辅助治疗或辅助治疗药。
Objective: to evaluate the status quo of the application of neoadjuvant chemotherapy. 目的:对新辅助化疗方案的临床应用现状进行评价。
Effects of Neoadjuvant Chemotherapy on P-gp, GST-π Expression in Breast Cancer 新辅助化疗对乳腺癌P-gp、GST-π的影响及意义
Neoadjuvant chemotherapy starts to show promising effects. 新辅助化疗也开始显示出良好疗效。
Objective To evaluate the clinical value of neoadjuvant chemotherapy for breast cancer on pathological stage and designing of therapy plan. 目的通过研究新辅助化疗对乳腺癌根治术后病理分期及治疗方案的影响,进一步评价新辅助化疗的临床价值。
Application of neoadjuvant chemotherapy for operable breast cancer 新辅助治疗在可手术乳腺癌中的应用
The Study of Short-Term Therapy Efficacy of Neoadjuvant Chemotherapy on Locally Advanced Cervical Carcinoma 新辅助化疗在局部晚期宫颈癌治疗中的近期疗效研究